Latest Regulatory News

Cann Group Limited announces a transformative $9 million capital raise alongside a major debt restructure, positioning the medicinal cannabis pioneer for profitability in FY26.

Talius Group has raised $4 million in a recent placement, expanding its subscription base and preparing to capitalize on new aged care legislation set to take effect in November 2025.

Talius Group has secured $4 million through an upsized placement, reflecting strong investor confidence in its remote care platform amid regulatory shifts in aged care funding.

Northern Minerals Limited (ASX – NTU) has launched a $60.5 million equity placement to fund the development of its Browns Range Heavy Rare Earths Project in Western Australia, supported by strategic partnerships and conditional debt backing from Australian and US government agencies.

Aeris Resources has agreed to sell its North Queensland copper assets to Dingo Minerals for up to $15.5 million, marking a strategic move to focus on core operations and strengthen its balance sheet.

BPH Global has inked a two-year commercial framework agreement with the Maluku provincial government entity to secure a steady seaweed supply and collaborate on a bio-stimulant manufacturing facility, boosting its footprint in Indonesia’s premium seaweed market.

Mt Malcolm Mines NL has announced a pro-rata renounceable entitlement issue to raise up to $2.33 million, partially underwritten by Mahe Capital Pty Ltd. The capital raise aims to fund exploration drilling, repay director loans, and support working capital.

Kaili Resources has responded to ASX inquiries regarding delays in confirming rare earth element assay results from recent drilling, reaffirming compliance with disclosure rules and explaining procedural factors behind the timing.

Redcastle Resources is set to restart exploration drilling with a focused 2,700-metre Reverse Circulation program targeting key gold prospects in Western Australia’s Redcastle Project Area. The campaign aims to deepen geological understanding and leverage joint venture synergies to advance resource potential.

PYC Therapeutics has reported significant progress across its four RNA therapeutic programs targeting genetic diseases, alongside a strong cash runway supporting ongoing development.

Artrya Limited has secured FDA clearance for its Salix Coronary Plaque module and raised $80 million to fuel its U.S. commercial expansion, marking a pivotal step in its transition from development to revenue generation.

First Au Limited has struck a deal granting AustChina Holdings an exclusive 19-month option to acquire its Eastern Victorian Goldfield Project, unlocking value from a non-core asset while sharpening focus on its African and Western Australian ventures.